Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
CEPI to expand COVID-19 vaccine testing network to other epidemic and pandemic diseases
Biopharma Reporter
Tue, 11/23/21 - 09:45 am
CEPI
vaccines
pandemic
COVID-19
epidemics
Covid antivirals could be pandemic game-changers. But Americans might struggle to access them
Stat
Tue, 11/23/21 - 09:41 am
antivirals
Pfizer
Merck
COVID-19
patient access
molnupiravir
Paxlovid
House COVID-19 panel seeks interview with former Trump FDA leader Hahn
The Hill
Mon, 11/22/21 - 10:21 pm
Stephen Hahn
FDA
Donald Trump
COVID-19
vaccines
Pfizer’s Covid-19 vaccine was 100% effective in kids in longer-term study
Stat
Mon, 11/22/21 - 10:27 am
Pfizer
BioNTech
COVID-19
vaccines
adolescents
FDA asks for 55 years to complete FOIA request on Pfizer's COVID-19 vaccine | FiercePharma
Fierce Pharma
Sat, 11/20/21 - 12:03 pm
Pfizer
vaccines
COVID-19
FDA
FOIA
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Regeneron
Roche
COVID-19
antibodies
FDA expands emergency authorization for Covid-19 booster shots to all adults
Stat
Fri, 11/19/21 - 11:15 am
FDA
Moderna Therapeutics
Pfizer
BioNTech
vaccines
COVID-19
boosters
Emergency Use Authorization
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
Motley Fool
Fri, 11/19/21 - 10:52 am
Merck
Pfizer
antivirals
COVID-19
molnupiravir
Paxlovid
Covid-19 takes its toll on medtechs’ efficiency
EP Vantage
Fri, 11/19/21 - 10:51 am
Medtech
devices
pandemic
COVID-19
revenue per employee
White House preps to pump billions into mRNA vaccine manufacturing capacity — but Moderna and Pfizer will have to buy in
Endpoints
Thu, 11/18/21 - 10:55 pm
White House
vaccines
drug manufacturing
MRNA
COVID-19
Passive vaccination? AstraZeneca spotlights six-month protection with Covid-19 antibody among vulnerable group
Endpoints
Thu, 11/18/21 - 10:44 am
AstraZeneca
COVID-19
antibodies
passive vaccination
Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haul
Fierce Pharma
Thu, 11/18/21 - 10:39 am
Pfizer
COVID-19
government contracts
antivirals
Paxlovid
CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine
Yahoo Finance
Thu, 11/18/21 - 10:36 am
CureVac
MRNA
vaccines
COVID-19
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week
NY Times, NY
Wed, 11/17/21 - 11:25 pm
Pfizer
COVID-19
vaccines
boosters
FDA
US to invest billions to increase COVID-19 vaccine supply
Beckers Hospital Review
Wed, 11/17/21 - 11:22 pm
vaccines
COVID-19
White House
Moderna asks FDA to approve boosters for all adults
Beckers Hospital Review
Wed, 11/17/21 - 11:19 pm
Moderna Therapeutics
COVID-19
vaccines
FDA
boosters
Johnson and Johnson’s new vaccines leader talks Covid-19, pipeline plans, and ‘a golden opportunity’ for clinical trials
Stat
Wed, 11/17/21 - 10:55 am
JNJ
vaccines
Penny Heaton
COVID-19
clinical trials
Spend, spend, spend: How biopharma consumable suppliers invested through a crisis
Biopharma Reporter
Wed, 11/17/21 - 10:34 am
biopharma consumables
consumables
Danaher
Thermo Fisher
COVID-19
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
Fierce Biotech
Wed, 11/17/21 - 10:28 am
Roche
Merck
Pfizer
Atea Pharmaceuticals
COVID-19
EU decision on Novavax COVID-19 shot could come 'within weeks'
Yahoo/Reuters
Wed, 11/17/21 - 10:25 am
Novavax
Europe
COVID-19
vaccines
Nuvaxovid
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »